FDA Drug Approval, A210317, OCTREOTIDE ACETATE

FDA Drug Approval, A210317, OCTREOTIDE ACETATE

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
ANDA: 210317
Company: TEVA PHARMS USA INC
Drug Name: OCTREOTIDE ACETATE
Active Ingredients: OCTREOTIDE ACETATE
Strength: EQ 30MG BASE/VIAL
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/05/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
View full details